Moderna
MRNA
#270
Rank
$89.82 B
Marketcap
$225.00
Share price
14.21%
Change (1 day)
717.29%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -$3.05 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $2.21 Billion USD. In 2025 the company made an earning of -$2.76 Billion USD, an increase over its 2024 earnings that were of -$3.59 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$3.05 Billion10.41%
2025 -$2.76 Billion-23.03%
2024 -$3.59 Billion-8.22%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$26.20 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.52 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$7.69 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-$47.43 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$1.12 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-$0.16 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA